Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVERT: Eszopiclone adjunctive to venlafaxine in MDD with insomnia
2006-001529-24Phase 3Completed
- Sponsor
- Sunovion
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) and Insomnia comparing Venlafaxine + eszopiclone 3 mg with Venlafaxine + placebo (2 arms). Primary endpoint: Primary: Change in HAM-D-17 total score at 8 weeks. Started Oct 2006; status: completed.
02
Drugs
eszopiclonevenlafaxine
03
Conditions
major depressive disorder (MDD)Insomnia
Beyond the preview
Go deeper on 2006-001529-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001529-24.